Alan B. Sandler Mirati Therapeutics, Inc. (MRTX) insider trading activity

MRTX Quotes by TradingView

Alan B. Sandler is Chief Medical Officer of Mirati Therapeutics, Inc.. Currently has a direct ownership of 0 shares of MRTX, which is worth approximately $0. The most recent transaction as insider was on Jan 23, 2024, when has been sold 79,865 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
100.0% 12M change
Total Value Held $0

Alan B. Sandler Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 23 2024
SELL
Sale (or disposition) back to the issuer
-
79,865 Reduced 100.0%
0 Common Stock
Dec 29 2023
BUY
Grant, award, or other acquisition
$999,983 $58.75 p/Share
17,021 Added 17.67%
79,318 Common Stock
Aug 09 2023
BUY
Grant, award, or other acquisition
$824,989 $37.0 p/Share
22,297 Added 26.36%
62,297 Common Stock
Nov 07 2022
BUY
Grant, award, or other acquisition
-
40,000 Added 50.0%
40,000 Common Stock

Also insider at

ZLAB
Zai Lab Ltd Healthcare
Head of Global Dev., Oncology
ELEV
Elevation Oncology, Inc. Healthcare
ALXO
ALX ONCOLOGY HOLDINGS INC Healthcare
Chief Medical Officer
ABS

Alan B. Sandler

Chief Medical Officer
Cambridge, MA

Track Institutional and Insider Activities on MRTX

Follow Mirati Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MRTX shares.

Notify only if

Insider Trading

Get notified when an Mirati Therapeutics, Inc. insider buys or sells MRTX shares.

Notify only if

News

Receive news related to Mirati Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on MRTX